MedTrace Logo

Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children

NCT05861687 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 51

Last updated 2023-05-17

No results posted yet for this study

Summary

This study aims to compare the recurrence rates of Esomeprazole and Lansoprazole in triple combination therapy to eradicate H.pylori infection in children. The participants were divided into two groups, those who received Esomeprazole and those who received Lansoprazole

Conditions

  • Helicobacter Pylori Infection

Interventions

DRUG

Esomeprazole

Administered once a day per-oral (PO) with the dose of 0.4 mg/kg

DRUG

Lansoprazole

Administered once a day per-oral (PO) with the dose of 15 mg if individual's body mass was \<30 kg, and 30 mg if it was \>30 kg

DRUG

Amoxicillin

Administered thrice a day per-oral (PO) with the dose of 25 mg/kg

DRUG

Clarithromycin

Administered twice a day per-oral with the dose of 7.5 mg/kg

Sponsors & Collaborators

  • Finni Kollins

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-01
Primary Completion
2021-12-07
Completion
2022-05-20

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05861687 on ClinicalTrials.gov